Is a complete AURA research report available?

No complete published report is available for Aura Biosciences, Inc. (AURA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · USD

$6.39

+0.09 (+1.4%)· Recorded snapshot

Market cap	662.7M
Net income (ttm)	-131M
EPS (ttm)	-$1.77
Shares out	103.7M
Volume	403,813
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -131M
EPS (ttm): -$1.77
Market cap: 662.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001501796
Company name	Aura Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	05153U107
Earnings date	2026-11-12
Earnings time	bmo
Employees	113
Employees change	4
Employees growth	3.67%
Enterprise value	$355.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-10-29
Is primary listing	Yes
Is SPAC	No
ISIN number	US05153U1079
Last 10-K release date	2026-03-30
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$662.7M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$6.39
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	AURA
U.S. state	Massachusetts
Website	https://www.aurabiosciences.com

Metric

Value

Amount currency

USD

CIK code

0001501796

Company name

Aura Biosciences, Inc.

Country

United States

Country code

CUSIP number

05153U107

Earnings date

2026-11-12

Earnings time

bmo

Employees

113

Employees change

Employees growth

3.67%

Enterprise value

$355.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2007

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-10-29

Is primary listing

Yes

Is SPAC

ISIN number

US05153U1079

Last 10-K release date

2026-03-30

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$662.7M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$6.39

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

AURA

U.S. state

Massachusetts

Website

https://www.aurabiosciences.com

Metric	Value
Earnings yield	-27.74%
FCF / EV yield	-30.13%
FCF yield	-15.89%
P/B ratio	2.07x
Price / tangible book value	2.06x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-27.74%

FCF / EV yield

-30.13%

FCF yield

-15.89%

P/B ratio

2.07x

Price / tangible book value

2.06x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.2M
ROA	-31.24%
ROA (5Y)	-26.7%
ROCE	-42.02%
ROE	-53.49%
ROE (5Y)	-46.13%
ROIC	-32.9%

Metric

Value

Profit per employee

$-1.2M

ROA

-31.24%

ROA (5Y)

-26.7%

ROCE

-42.02%

ROE

-53.49%

ROE (5Y)

-46.13%

ROIC

-32.9%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-344,000
Depreciation and amortization	$1.1M
EBIT	$-138.1M
EBITDA	$-137M
EPS	$-1.77
FCF per share	$-1.00
Financing cash flow	$249.2M
Free cash flow	$-103.4M
Free cash flow minus SBC	$-126.5M
Income taxes	$81,000
Investing cash flow	$-185.3M
Net cash flow	$-39.5M
Net income	$-131M
Operating cash flow minus SBC	$-126.2M
Operating income	$-138.1M
Stock-based compensation	$23.2M

Metric

Value

Capital expenditures

$-344,000

Depreciation and amortization

$1.1M

EBIT

$-138.1M

EBITDA

$-137M

EPS

$-1.77

FCF per share

$-1.00

Financing cash flow

$249.2M

Free cash flow

$-103.4M

Free cash flow minus SBC

$-126.5M

Income taxes

$81,000

Investing cash flow

$-185.3M

Net cash flow

$-39.5M

Net income

$-131M

Operating cash flow minus SBC

$-126.2M

Operating income

$-138.1M

Stock-based compensation

$23.2M

Metric	Value
Book value per share	$3.05
Debt / equity	0.05
Long-term assets	$19.1M
Long-term liabilities	$13.3M
Net cash (debt)	$307.2M
Net cash / market cap	47.25%
Net cash growth	92.99%
Net debt / equity	-0.97
Piotroski F-Score	2
Property, plant and equipment	$17.2M
Shareholders' equity	$315.3M
Tangible book value	$315.3M
Tangible book value per share	$3.05
Total assets	$348.1M
Total cash	$323.8M
Total debt	$16.6M
Total liabilities	$32.9M
WACC	6.36%

Metric

Value

Book value per share

$3.05

Debt / equity

0.05

Long-term assets

$19.1M

Long-term liabilities

$13.3M

Net cash (debt)

$307.2M

Net cash / market cap

47.25%

Net cash growth

92.99%

Net debt / equity

-0.97

Piotroski F-Score

Property, plant and equipment

$17.2M

Shareholders' equity

$315.3M

Tangible book value

$315.3M

Tangible book value per share

$3.05

Total assets

$348.1M

Total cash

$323.8M

Total debt

$16.6M

Total liabilities

$32.9M

WACC

6.36%

Metric	Value
Current assets	$329M
Current liabilities	$19.6M
Current ratio	16.82
Net working capital	$-11.1M
Quick ratio	16.65
Working capital	$309.5M

Metric

Value

Current assets

$329M

Current liabilities

$19.6M

Current ratio

16.82

Net working capital

$-11.1M

Quick ratio

16.65

Working capital

$309.5M

Metric	Value
Buyback yield / dilution	-42.27%
Dividend yield	0%
Shareholder yield	-42.27%

Metric

Value

Buyback yield / dilution

-42.27%

Dividend yield

Shareholder yield

-42.27%

Metric	Value
150-day SMA	$7.02
1D price change	1.43%
1M price change	6.5%
1M total return	6.5%
1W price change	-1.08%
1W total return	-1.08%
1Y price change	4.75%
1Y return CAGR	4.76%
1Y total return	4.75%
20-day SMA	$6.32
200-day SMA	$6.71
3M price change	-10.75%
3M total return	-10.75%
3Y price change	-11.86%
3Y return CAGR	-4.12%
3Y total return	-11.86%
50-day SMA	$6.74
50-day SMA vs 200-day SMA	50over200
52-week high	$9.54
52-week high date	2026-05-05
52-week low	$4.73
52-week low date	2026-01-20
6M price change	-8.19%
6M total return	-8.19%
All-time high	$26.16
All-time high date	2021-11-16
All-time low	$4.35
All-time low date	2025-05-15
Average true range (ATR)	$0.28
Average volume	921.1K
Beta (1Y)	1.79
Beta (2Y)	1.59
Beta (5Y)	0.41
Change from 52-week high	-32.98%
Change from 52-week low	35.1%
Change from all-time high	-75.57%
Change from all-time low	47.07%
Change from open	1.11%
Day's gap	0.32%
Dollar volume	$2.6M
High price	$6.40
Low price	$6.23
Monthly RSI	43.99
Open price	$6.32
Position in 52-week range	94.12%
Previous close	$6.30
Price vs 150-day SMA	-8.99%
Price vs 20-day SMA	1.12%
Price vs 200-day SMA	-4.71%
Price vs 50-day SMA	-5.24%
Relative volume	0.44
Return from IPO open	-55.53%
Return from IPO price	-55.21%
RSI	48.97
Sharpe ratio	0.28
Sharpe ratio (3Y)	0.09
Sortino ratio	0.59
Sortino ratio (3Y)	0.24
Volume	403.8K
Weekly RSI	46.27
YTD price change	17.25%
YTD total return	17.25%

Metric

Value

150-day SMA

$7.02

1D price change

1.43%

1M price change

6.5%

1M total return

6.5%

1W price change

-1.08%

1W total return

-1.08%

1Y price change

4.75%

1Y return CAGR

4.76%

1Y total return

4.75%

20-day SMA

$6.32

200-day SMA

$6.71

3M price change

-10.75%

3M total return

-10.75%

3Y price change

-11.86%

3Y return CAGR

-4.12%

3Y total return

-11.86%

50-day SMA

$6.74

50-day SMA vs 200-day SMA

50over200

52-week high

$9.54

52-week high date

2026-05-05

52-week low

$4.73

52-week low date

2026-01-20

6M price change

-8.19%

6M total return

-8.19%

All-time high

$26.16

All-time high date

2021-11-16

All-time low

$4.35

All-time low date

2025-05-15

Average true range (ATR)

$0.28

Average volume

921.1K

Beta (1Y)

1.79

Beta (2Y)

1.59

Beta (5Y)

0.41

Change from 52-week high

-32.98%

Change from 52-week low

35.1%

Change from all-time high

-75.57%

Change from all-time low

47.07%

Change from open

1.11%

Day's gap

0.32%

Dollar volume

$2.6M

High price

$6.40

Low price

$6.23

Monthly RSI

43.99

Open price

$6.32

Position in 52-week range

94.12%

Previous close

$6.30

Price vs 150-day SMA

-8.99%

Price vs 20-day SMA

1.12%

Price vs 200-day SMA

-4.71%

Price vs 50-day SMA

-5.24%

Relative volume

0.44

Return from IPO open

-55.53%

Return from IPO price

-55.21%

RSI

48.97

Sharpe ratio

0.28

Sharpe ratio (3Y)

0.09

Sortino ratio

0.59

Sortino ratio (3Y)

0.24

Volume

403.8K

Weekly RSI

46.27

YTD price change

17.25%

YTD total return

17.25%

Metric	Value
Float	74.6M
Float percentage	71.98%
Shares change (QoQ)	40.65%
Shares change (YoY)	42.27%
Shares held by insiders	1.2%
Shares held by institutions	67.62%
Shares outstanding	103.7M
Short % of float	13.89%
Short % of shares	10%
Short ratio	11.9 days

Metric

Value

Float

74.6M

Float percentage

71.98%

Shares change (QoQ)

40.65%

Shares change (YoY)

42.27%

Shares held by insiders

1.2%

Shares held by institutions

67.62%

Shares outstanding

103.7M

Short % of float

13.89%

Short % of shares

10%

Short ratio

11.9 days

Aura Biosciences, Inc. (AURA)

Price

Financial snapshot

Fair-value bridge

Latest news · AURA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AURA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AURA

Frequently asked questions